Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells.
暂无分享,去创建一个
E. Montserrat | N. Villamor | D. Colomer | G. Pons | J. Gil | M. Barragán | B. Bellosillo | M. Piqué | E. Castaño | Emili Montserrat | Dolors Colomer | Beatriz Bellosillo | Joan Gil | Esther Castaño
[1] G.,et al. Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis , 2000 .
[2] D. Colomer,et al. Mitoxantrone, a topoisomerase II inhibitor, induces apoptosis of B‐chronic lymphocytic leukaemia cells , 1998, British journal of haematology.
[3] B. Rigas,et al. Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells. , 1998, Biochemical pharmacology.
[4] J. López-Belmonte,et al. Selective induction of cyclo‐oxygenase‐2 activity in the permanent human endothelial cell line HUV‐EC‐C: biochemical and pharmacological characterization , 1997, British journal of pharmacology.
[5] D. Colomer,et al. Involvement of CED-3/ICE proteases in the apoptosis of B-chronic lymphocytic leukemia cells. , 1997, Blood.
[6] Weiya Ma,et al. Inhibition of Activator Protein 1 Activity and Neoplastic Transformation by Aspirin* , 1997, The Journal of Biological Chemistry.
[7] J. Vilček,et al. Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[8] Y. Hannun,et al. Apoptosis and the dilemma of cancer chemotherapy. , 1997, Blood.
[9] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[10] R. Langenbach,et al. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid. , 1997, The Journal of pharmacology and experimental therapeutics.
[11] R. Bartrons,et al. Inhibition of DNA synthesis by aspirin in Swiss 3T3 fibroblasts. , 1997, The Journal of pharmacology and experimental therapeutics.
[12] William L. Smith,et al. Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2* , 1996, The Journal of Biological Chemistry.
[13] E. Krebs,et al. Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Memo,et al. Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation , 1996, Science.
[15] Marty W. Mayo,et al. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.
[16] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[17] Michael Karin,et al. Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.
[18] Jilly F. Evans,et al. Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells. , 1996, Biochemical pharmacology.
[19] D. Katz,et al. Inhibition of NF‐kappaB/Rel induces apoptosis of murine B cells. , 1996, The EMBO journal.
[20] B. Rigas,et al. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. , 1996, Biochemical pharmacology.
[21] S. Korsmeyer,et al. Molecular thanatopsis: a discourse on the BCL2 family and cell death. , 1996, Blood.
[22] M. Arsura,et al. TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBα , 1996 .
[23] F. Luscinskas,et al. Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. , 1996, Journal of immunology.
[24] John Calvin Reed,et al. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. , 1996, Oncogene.
[25] P. Blackshear,et al. Characterization and purification of a protein kinase C substrate in human B cells. Identification as lymphocyte-specific protein 1 (LSP1). , 1996, Journal of immunology.
[26] P. Henkart. ICE family proteases: mediators of all apoptotic cell death? , 1996, Immunity.
[27] B. Rigas,et al. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. , 1996, Experimental cell research.
[28] D. Baltimore,et al. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. , 1996, Science.
[29] D. Hicks,et al. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines. , 1996, Cancer research.
[30] M. Arsura,et al. TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. , 1996, Immunity.
[31] D F Roychowdhury,et al. Aspirin and the risk of colorectal cancer in women. , 1996, The New England journal of medicine.
[32] D. Forman,et al. Aspirin, non-steroidal anti-inflammatory drugs and protection from colorectal cancer: a review of the epidemiological evidence. , 1996, Scandinavian journal of gastroenterology. Supplement.
[33] R. DuBois,et al. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.
[34] E. Montserrat,et al. Chronic lymphocytic leukemia. , 1995, The New England journal of medicine.
[35] G. Piazza,et al. Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac. , 1995, Journal of the National Cancer Institute.
[36] D. Reed,et al. Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[37] D. Alberts,et al. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. , 1995, Cancer research.
[38] B. Rigas,et al. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. , 1995, The Journal of clinical investigation.
[39] W. Erl,et al. Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells. , 1995, Circulation.
[40] L. Rosenberg. Nonsteroidal anti-inflammatory drugs and cancer. , 1995, Preventive medicine.
[41] J. Gierse,et al. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. , 1995, The Biochemical journal.
[42] H. Chan,et al. Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. , 1994, Biochimica et biophysica acta.
[43] E. Montserrat,et al. Recent progress in chronic lymphocytic leukemia. International Workshop on chronic Lymphocytic Leukemia. , 1994, Leukemia.
[44] S. Ghosh,et al. Inhibition of NF-kappa B by sodium salicylate and aspirin. , 1994, Science.
[45] I. Behrmann,et al. Regulation of apoptosis in the immune system. , 1994, Current opinion in immunology.
[46] K. Lee,et al. Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacy. , 1994, Leukemia.
[47] M. Story,et al. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine , 1993 .
[48] J. Travers,et al. Aspirin use and reduced risk of fatal colon cancer. , 1992, The New England journal of medicine.
[49] I Nicoletti,et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.
[50] S. Shapiro,et al. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. , 1991, Journal of the National Cancer Institute.
[51] S. Orrenius,et al. Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. , 1991, Journal of immunology.
[52] A. Saven,et al. 2-Chlorodeoxyadenosine chemotherapy triggers programmed cell death in normal and malignant lymphocytes. , 1991, Advances in experimental medicine and biology.
[53] K. Foon,et al. Chronic lymphocytic leukemia: new insights into biology and therapy. , 1990, Annals of internal medicine.
[54] W. Smith,et al. The eicosanoids and their biochemical mechanisms of action. , 1989, The Biochemical journal.
[55] J. Salmon,et al. Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[56] M. Leider. Goodman & Gilman's The Pharmacological Basis of Therapeutics , 1985 .
[57] E. Huskisson,et al. Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use. , 1984, Drugs.
[58] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[59] Mark J. Thomas,et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis , 1981, Cancer.
[60] W. M. Heller,et al. The United States Pharmacopeial Convention, Inc , 1977 .
[61] J. Vane,et al. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.
[62] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.